Literature DB >> 9638669

Optimisation of unenhanced MRI for detection of lesions in multiple sclerosis: a comparison of five pulse sequences with variable slice thickness.

N Tubridy1, G J Barker, D G MacManus, I F Moseley, D H Miller.   

Abstract

We used five MRI sequences in six patients with multiple sclerosis (MS): conventional spin-echo (CSE) with 5-mm slices; 2D fast spin-echo (FSE) with 2-mm slices; multishot T2*-weighted echo-planar imaging (EPI) with 5-mm slices; fast fluid-attenuated inversion recovery (fFLAIR) with 2-mm slices; and 3D fast spin-echo with 1.5-mm-thick slices. A total of 225 lesions were detected on CSE, 274 on 2D FSE, 137 on EPI, 385 on fFLAIR and 320 on 3D FSE. The EPI sequence was clearly the least sensitive and susceptibility artefact was a problem, particularly in the brain stem and temporal lobes. Fast FLAIR displayed a much higher number of supratentorial lesions (380) than 3D FSE (297), 2D FSE (264) or CSE (211). However, in the posterior cranial fossa 3D FSE was the most sensitive sequence (23 lesions), followed by CSE (14) and 2D FSE (10), while fFLAIR (5) was extremely insensitive.

Entities:  

Mesh:

Year:  1998        PMID: 9638669     DOI: 10.1007/s002340050587

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  3 in total

1.  Reduction of CSF artifacts on FLAIR images by using adiabatic inversion pulses.

Authors:  J V Hajnal; A Oatridge; A H Herlihy; G M Bydder
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Detection of lesions in multiple sclerosis by 2D FLAIR and single-slab 3D FLAIR sequences at 3.0 T: initial results.

Authors:  Andrea Bink; Melanie Schmitt; Jochen Gaa; John P Mugler; Heinrich Lanfermann; Friedhelm E Zanella
Journal:  Eur Radiol       Date:  2006-01-20       Impact factor: 5.315

3.  FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla.

Authors:  Rainald Bachmann; Ralf Reilmann; Wolfram Schwindt; Harald Kugel; Walter Heindel; Stefan Krämer
Journal:  Eur Radiol       Date:  2005-12-20       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.